The a2 Milk Company Limited reported revenue growth of 12.4% for the financial year to 30 June 2026, reaching NZ$1.974 billion. However, this top-line expansion masks a sharper decline in profitability, with net profit attributable to security holders falling 44.0% to NZ$113.6 million. This divergence between revenue and earnings growth signals pressure on margins or operating costs that investors will need to understand in detail from the full annual report.
The profit from continuing ordinary activities before attribution fell to NZ$207.5 million, a decline of 5.8% year-on-year, which provides additional context for the steeper net profit drop. This suggests that while the core business remains profitable, the company faced headwinds during the period. These could stem from input cost inflation, supply chain pressures, competitive intensity in key markets, or elevated operating expenses. For investors holding a2M shares, this represents a material shift in earnings power relative to the prior year’s performance.
Dividend payments during the year were substantial, including an interim dividend of NZ$0.09500 per security, a special dividend of NZ$0.04928571 per security, and a final dividend of NZ$0.04071429 per security approved subsequent to year-end. The prior year’s final dividend was NZ$0.11500 per security. The total dividend distribution was materially lower than the prior year despite the challenging earnings environment, suggesting management’s caution about future cash generation. The franking levels on these dividends ranged from 4.1% to 17.7%, indicating limited Australian tax credits, which is relevant for Australian investors in the fund.
The decline in net tangible assets per security from NZ$1.79 to NZ$1.12 is a significant concern, representing a 37% reduction in book value per share. This substantial deterioration warrants careful examination of the balance sheet to understand whether it reflects earnings retention policy, share buybacks, impairments, or other capital allocation decisions. A sharp contraction in NTA per security often signals either challenging trading conditions or deliberate capital management, and the annual report commentary should clarify which factor was dominant.
Investors should closely examine the full annual report and results commentary to identify the drivers of margin compression and the sustainability of the dividend policy given the earnings decline. The company’s competitive position in infant formula markets, currency movements affecting its predominantly export-focused business, and management’s strategic outlook for the coming year will be critical to assessing whether this period represents a cyclical downturn or a structural shift in the business. This announcement has been flagged by the ASX as price sensitive and material to investors.
View the full ASX announcement (PDF)
About The a2 Milk Company Limited (ASX: A2M)
The a2 Milk Company Limited is a dairy nutritionals company that sells A2-type protein branded milk and related products, including infant milk formula and other dairy products. The company operates across Australia, New Zealand, China, rest of Asia, and the United States, manufacturing and selling nutritional products and providing licensing services under the a2 Milk and a2 Platinum brands.
If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.
